S&P 500 Futures
(0.06%) 5 157.75 points
Dow Jones Futures
(0.08%) 38 862 points
Nasdaq Futures
(-0.04%) 17 993 points
Oil
(0.45%) $78.46
Gas
(0.56%) $2.15
Gold
(0.45%) $2 318.90
Silver
(1.78%) $27.17
Platinum
(-0.27%) $962.70
USD/EUR
(0.02%) $0.929
USD/NOK
(-0.18%) $10.85
USD/GBP
(0.00%) $0.797
USD/RUB
(0.05%) $91.50

实时更新: PeptiDream Inc. [4587.T]

交易所: JPX 部门: Healthcare 工业: Biotechnology
Upcoming Earnings Alert

2 days till quarter result
(bmo 2024-05-08)

Expected move: +/- 0.00%

最后更新时间2 May 2024 @ 14:15

-4.13% ¥ 1 995.00

Live Chart Being Loaded With Signals

Commentary (2 May 2024 @ 14:15):

PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics...

Stats
今日成交量 1.79M
平均成交量 929 681
市值 258.57B
EPS ¥0 ( 2024-02-14 )
下一个收益日期 ( ¥10.93 ) 2024-05-08
Last Dividend ¥0 ( N/A )
Next Dividend ¥0 ( N/A )
P/E 85.48
ATR14 ¥3.03 (0.15%)

音量 相关性

長: -0.02 (neutral)
短: 0.35 (neutral)
Signal:(59.562) Neutral

PeptiDream Inc. 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

PeptiDream Inc. 相关性 - 货币/商品

The country flag -0.13
( neutral )
The country flag -0.05
( neutral )
The country flag 0.23
( neutral )
The country flag 0.24
( neutral )
The country flag -0.05
( neutral )

PeptiDream Inc. 财务报表

Annual 2023
营收: ¥28.71B
毛利润: ¥16.86B (58.73 %)
EPS: ¥23.41
FY 2023
营收: ¥28.71B
毛利润: ¥16.86B (58.73 %)
EPS: ¥23.41
FY 2022
营收: ¥26.85B
毛利润: ¥18.11B (67.46 %)
EPS: ¥58.19
FY 2021
营收: ¥9.37B
毛利润: ¥7.01B (74.82 %)
EPS: ¥28.70

Financial Reports:

No articles found.

PeptiDream Inc.

PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform for the development of peptides. It has a collaborative research and exclusive license agreement with Takeda Pharmaceutical Company Limited to develop peptide drug conjugates for neuromuscular diseases. The company was incorporated in 2006 and is headquartered in Kawasaki, Japan.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。